Skip to Content
Merck
CN
  • Differential effects of fatty acyl coenzyme A derivatives on citrate synthase and glutamate dehydrogenase.

Differential effects of fatty acyl coenzyme A derivatives on citrate synthase and glutamate dehydrogenase.

Research communications in chemical pathology and pharmacology (1993-12-01)
J C Lai, B B Liang, E J Jarvi, A J Cooper, D R Lu
ABSTRACT

We investigated the hypothesis that one mechanism underlying fatty acid toxicity is the selective inhibition of rate-limiting and/or regulated tricarboxylic acid cycle and related enzymes by fatty acyl coenzyme A (CoA) derivatives by examining the effects of several fatty acyl CoAs on purified citrate synthase (CS) and glutamate dehydrogenase (GDH). The results indicate that, at pathophysiological levels, palmitoyl CoA, a long-chain acyl CoA, is a potent inhibitor of CS and GDH with IC50 values of 3-15 microM. At much higher levels (in the pathological and toxicological range), octanoyl and decanoyl CoA (medium-chain acyl CoAs) inhibited both enzymes with IC50 values of 0.4-1.6 mM. Butyryl CoA, a short-chain acyl CoA, inhibited CS (IC50 = 0.9 mM) at toxicological levels but inhibited GDH poorly. These results suggest that the long-chain fatty acyl CoA inhibition of CS and GDH may assume some pathophysiological importance in fatty acid toxicity and in metabolic encephalopathies in which organic acidemia is persistent. The findings also provide additional support for the original hypothesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Decanoyl coenzyme A monohydrate, ≥90%
Avanti
08:0 Coenzyme A, Avanti Polar Lipids 870708P, powder
Avanti
04:0 Coenzyme A, Avanti Polar Lipids